Core Insights - The incidence and mortality rates of prostate cancer among men in China are rising, posing a significant public health issue [1] - The treatment paradigm for prostate cancer is evolving from single-agent therapies to combination therapies and precision medicine, supported by advancements in AI and talent development [1][3] Group 1: Current Situation and Challenges - Prostate cancer's five-year survival rate in China has increased to over 70%, but it still lags behind the over 95% rate in developed countries [2] - There is an urgent need to enhance public awareness and early screening for high-risk groups, including men over 50 and those with a family history [2] Group 2: Treatment Advances - Endocrine therapy remains the cornerstone of prostate cancer treatment, significantly delaying tumor growth and controlling disease progression [3] - The shift from surgical castration to medical castration has become mainstream due to equivalent clinical efficacy, with new androgen deprivation therapies emerging [2][3] Group 3: Future Directions - The challenge of treatment resistance in advanced prostate cancer is driving clinical research into new therapies, including AKT inhibitors, CAR-T cell therapy, and PSMA-targeted radiotherapy [4] - Ongoing development of tumor vaccines for prostate cancer indicates a proactive approach to treatment across different disease stages [4]

Core Insights - Prostate cancer, often referred to as "retirement cancer," poses a significant health threat to older men globally, with rising incidence and mortality rates necessitating increased public awareness and standardized treatment protocols [1][2] Group 1: Awareness and Education Initiatives - The Beijing Integrative Medicine Association has launched a health education project for prostate cancer patients, aiming to enhance knowledge about the disease and treatment options through online and offline meetings [1] - During the National Cancer Week from April 15-21, a health education event was held by the Urology Department of Beijing Hospital, emphasizing the importance of early screening for prostate cancer [1] Group 2: Screening and Diagnosis - Early detection is crucial, as prostate cancer often progresses slowly, leading to late diagnoses when symptoms become apparent [2][3] - The prostate-specific antigen (PSA) test is an effective and affordable screening method, yet many elderly men have not undergone this test [3] - Recommendations suggest that men over 50 should have regular PSA screenings, with follow-up procedures based on PSA levels [3][4] Group 3: Treatment Approaches - The survival rate for prostate cancer patients is closely linked to the cancer stage at diagnosis, with early-stage patients having a higher likelihood of being cured through radical surgery or radiation [6] - For high-risk patients without metastasis, hormonal therapy may be used to shrink tumors before curative treatments [6] - Ongoing management and follow-up are essential in the treatment of prostate cancer to assess effectiveness and prevent treatment discontinuation [6]